Please wait while we load the requested 20-F report or click the link below:
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , and by Alterity Therapeutics Ltd.
Inside this 20-F Annual Report
Document And Entity Information Consolidated Cash Flow Statements Consolidated Statements Of Changes In Shareholders' Equity Consolidated Statements Of Financial Position Consolidated Statements Of Financial Position (Parentheticals) Consolidated Statements Of Profit Or Loss And Other Comprehensive Loss Consolidated Statements Of Profit Or Loss And Other Comprehensive Loss (Parentheticals) Accounting Policies, By Policy (Policies) Accumulated Deficit During Development StageAccumulated Deficit During Development Stage (Details) - Schedule Of Accumulated Deficit During Development Stage
Accumulated Deficit During Development Stage (Tables) Auditors' Remuneration Auditors' Remuneration (Details) - Schedule Of Audit And Review Of Financial Statements Auditors' Remuneration (Tables) Background And Summary Of Significant Accounting Policies Background And Summary Of Significant Accounting Policies (Details)Background And Summary Of Significant Accounting Policies (Details) - Schedule Of Estimated Useful Lives
Background And Summary Of Significant Accounting Policies (Tables) Cash Flow Information Cash Flow Information (Details) - Schedule Of Cash Flow Information Cash Flow Information (Tables) Commitments And Contingencies Commitments And Contingencies (Details) Expenditure Commitments Expenditure Commitments (Details) Expenses From Ordinary Activities Expenses From Ordinary Activities (Details) - Schedule Of Expenses From Ordinary Activities Expenses From Ordinary Activities (Tables) Financial Instruments Financial Instruments (Details)Financial Instruments (Details) - Schedule Of Company's Liquidity Reserve On The Basis Of Expected Cash Flows
Financial Instruments (Details) - Schedule Of Financial Assets And Liabilities Subject To Foreign Currency Risk
Financial Instruments (Details) - Schedule Of Interest Rates And The Effective Weighted Average Interest Rate For Classes Of Financial Assets And Liabilities
Financial Instruments (Tables) Income Tax Income Tax (Details) Income Tax (Details) - Schedule Of Income Tax Income Tax (Details) - Schedule Of Income Tax (Parentheticals) Income Tax (Tables) Interest And Other Income From Continuing Operations Interest And Other Income From Continuing Operations (Details)Interest And Other Income From Continuing Operations (Details) - Schedule Of Interest And Other Income From Continuing Operations
Interest And Other Income From Continuing Operations (Tables) Issued Capital Issued Capital (Details) - Schedule Of Issued Capital Issued Capital (Details) - Schedule Of Issued Capital (Parentheticals) Issued Capital (Details) - Schedule Of Movements In Issued Shares Issued Capital (Details) - Schedule Of Share Issuances Issued Capital (Tables) Key Management Personnel Compensation Key Management Personnel Compensation (Details) - Schedule Of Key Management Personnel Compensation Key Management Personnel Compensation (Tables) Leases (Details) Leases (Details) - Schedule Of Financial Position Shows The Following Amounts Relating To Leases Leases (Details) - Schedule Of Profit Or Loss Shows The Following Amounts Relating To Leases Leases (Tables) Loss Per Share Loss Per Share (Details) - Schedule Of Earning Loss Per Share Loss Per Share (Details) - Schedule Of Earning Loss Per Share (Parentheticals) Loss Per Share (Tables) Other Current Assets Other Current Assets (Details) - Schedule Of Other Current Assets Other Current Assets (Tables) Parent Entity Financial InformationParent Entity Financial Information (Details) - Schedule Of Individual Financial Statements For The Parent Company
Parent Entity Financial Information (Tables) Provisions Provisions (Details) - Schedule Of Amounts Not Expected To Be Settled Within The Next 12 Months Provisions (Details) - Schedule Of Movements In Provisions Provisions (Details) - Schedule Of Provisions Provisions (Tables) Related Party Transactions Related Party Transactions (Details) Related Party Transactions (Details) - Schedule Of Directors Remuneration Related Party Transactions (Details) - Schedule Of Key Management Personnel Equity Holdings Related Party Transactions (Details) - Schedule Of Share Options Of The Company Related Party Transactions (Tables) Reserves (Details) Reserves (Details) - Schedule Of Movements In Options For Fully Paid Ordinary Shares Reserves (Details) - Schedule Of Reserves Of Share Based Payments Reserves (Details) - Schedule Of Reserves Of Share Based Payments (Parentheticals) Reserves (Tables) Segment Information Segment Information (Details) Share Based Payments Share Based Payments (Details) Share Based Payments (Details) - Schedule Of Options Granted Share Based Payments (Details) - Schedule Of Options Outstanding Share Based Payments (Details) - Schedule Of Shares Issued Under Stock Option Plan Share Based Payments (Details) - Schedule Of Valuations Of Options Approved And Issued Share Based Payments (Tables) Subsequent Events Subsequent Events (Details) Trade And Other Payables Trade And Other Payables (Details) - Schedule Of Trade And Other Payables Trade And Other Payables (Tables) Trade And Other Receivables Trade And Other Receivables (Details) Trade And Other Receivables (Details) - Schedule Of Trade And Other Receivables Trade And Other Receivables (Tables)Alterity Therapeutics Ltd provided additional information to their SEC Filing as exhibits
Exhibit 12.1: Certification Exhibit 12.2: Certification Exhibit 13.1: Certification Exhibit 13.2: Certification Exhibit 15.1: Consent Of Pricewaterhousecoopers Exhibit 15.2: Auditor'S Independence DeclarationTicker: ATHE
CIK: 1131343
Form Type: 20-F Annual Report
Accession Number: 0001213900-23-072629
Submitted to the SEC: Thu Aug 31 2023 9:15:39 AM EST
Accepted by the SEC: Thu Aug 31 2023
Period: Friday, June 30, 2023
Industry: Pharmaceutical Preparations
